期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 291, 期 4, 页码 987-994出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/bbrc.2002.6561
关键词
thyroid hormones; 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3); primary osteoblastic cells (POB); receptor activator of nuclear factor-kappa B ligand (RANIKL); osteoclast formation; iodothyronine deiodinase
Thyroid hormones enhance osteoclast formation and their excess is an important cause of secondary osteoporosis. 3,5,3'-Triiodo-L-thyronine (T3) induced the mRNA expression of receptor activator of nuclear factor-kappaB ligand (RANKL), which is a key molecule in osteoclast formation, in primary osteoblastic cells (POB). This effect was amplified in the copresence of 1alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3). Although T3 alone did not induce octeoclasts in coculture of bone marrow cells with POB, T3 enhanced 1,25(OH)(2)D-3-induced osteoclast formation. Thyroxine (T4) also enhanced 1,25(OH)(2)D-3-induced osteoclast formation. These data suggested that T4 was locally metabolized to T3 for its action, since T4 is a prohormone with little hormonal activity. The mRNA expression of type-2 iodothyronine deiodinase (D2), which is responsible for maintaining local T3 concentration, was induced by 1,25(OH)(2)D-3 dose- and time-dependently. Our data would facilitate our understanding of the mechanism of osteoclast formation by thyroid hormones and suggest a novel interaction between thyroid hormones and 1,25(OH)(2)D-3. (C) 2002 Elsevier Science (USA).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据